Antithrombotic Usage Indications in Atrial Fibrillation

被引：0

作者：

Akyol, Ahmet ^{[1
]}

机构：

[1] Acibadem Maslak Hastanesi Kardiyol Klin, TR-34457 Istanbul, Turkey

来源：

TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI | 2010年 / 27卷

关键词：

Atrial fibrillation; antithrombotic therapy; stroke; ACUTE ISCHEMIC-STROKE; RHYTHM-CONTROL; EARLY DEATH; SHORT-TERM; RISK; ASPIRIN; WARFARIN; THERAPY; PREVENTION; SEVERITY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice, accounting for approximately one-third of hospitalizations for cardiac rhythm disturbances. Stroke is the most important morbidity in AF patients. Antithrombotic therapy is the most effective way to prevent thromboembolic complications of AF. Also, ischemic stroke secondary to AF carry twice the risk of death when compared with strokes from other causes. In this review, we discuss the stroke risk stratification in AF patients and antithrombotic drug usage indication in different clinical situtations according to current published guidelines.

引用

页码：1 / 6

页数：6

共 40 条

[1] PREDICTORS OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION .1. CLINICAL-FEATURES OF PATIENTS AT RISK [J].

ANDERSON, DC ;

ASINGER, RW ;

NEWBURG, SM ;

FARMER, CC ;

WANG, K ;

BUNDLIE, SR ;

KOLLER, RL ;

JAGIELLA, WM ;

KREHER, S ;

JORGENSEN, CR ;

SHARKEY, SW ;

FLAKER, GC ;

WEBEL, R ;

NOLTE, B ;

STEVENSON, P ;

BYER, J ;

WRIGHT, W ;

CHESEBRO, JH ;

WIEBERS, DO ;

HOLLAND, AE ;

MILLER, DM ;

BARDSLEY, WT ;

LITIN, SC ;

MEISSNER, I ;

ZERBE, DM ;

MCANULTY, JH ;

MARCHANT, C ;

COULL, BM ;

FELDMAN, G ;

HAYWARD, A ;

GANDARA, E ;

MACMILLAN, K ;

BLANK, N ;

LEONARD, AD ;

KANTER, MC ;

ISENSEE, LM ;

QUIROGA, ES ;

PRESTI, CH ;

TEGELER, CH ;

LOGAN, WR ;

HAMILTON, WP ;

GREEN, BJ ;

BACON, RS ;

REDD, RM ;

CADELL, DJ ;

GOMEZ, CR ;

JANOSIK, DL ;

LABOVITZ, AJ ;

KELLEY, RE ;

CHAHINE, R .

ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) :1-5

[2] The primary and secondary prevention of coronary artery disease [J].

Becker, Richard C. ;

Meade, Thomas W. ;

Berger, Peter B. ;

Ezekowitz, Michael ;

O'Connor, Christopher M. ;

Vorchheimer, David A. ;

Guyatt, Gordon H. ;

Mark, Daniel B. ;

Harrington, Robert A. .

CHEST, 2008, 133 (06) :776S-814S

[3] Impact of atrial fibrillation on the risk of death [J].

Benjamin, EJ ;

Wolf, PA ;

D'Agostino, RB ;

Silbershatz, H ;

Kannel, WB ;

Levy, D .

CIRCULATION, 1998, 98 (10) :946-952

[4] Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study [J].

Berge, E ;

Abdelnoor, M ;

Nakstad, PH ;

Sandset, PM .

LANCET, 2000, 355 (9211) :1205-1210

[5] Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation - The Strategies of Treatment of Atrial Fibrillation (STAF) study [J].

Carlsson, J ;

Miketic, S ;

Windeler, J ;

Cuneo, A ;

Haun, S ;

Micus, S ;

Walter, S ;

Tebbe, U .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1690-1696

[6] Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation [J].

Conway, DSG ;

Pearce, LA ;

Chin, BSP ;

Hart, RG ;

Lip, GYH .

CIRCULATION, 2003, 107 (25) :3141-3145

[7] Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease - A meta-analysis of randomized trials [J].

Dentali, Francesco ;

Douketis, James D. ;

Lim, Wendy ;

Crowther, Mark .

ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (02) :117-124

[8]

FLEGEL KM, 1987, LANCET, V1, P526

[9] ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society [J].

Fuster, Valentin ;

Ryden, Lars E. ;

Cannom, David S. ;

Crijns, Harry J. ;

Curtis, Anne B. ;

Ellenbogen, Kenneth A. ;

Halperin, Jonathan L. ;

Le Heuzey, Jean-Yves ;

Kay, G. Neal ;

Lowe, James E. ;

Olsson, S. Bertil ;

Prystowsky, Eric N. ;

Tamargo, Juan Luis ;

Wann, Samuel .

CIRCULATION, 2006, 114 (07) :E257-E354

[10] Risk of thromboembolism with short-term interruption of warfarin therapy [J].

Garcia, David A. ;

Regan, Susan ;

Henault, Lori E. ;

Upadhyay, Ashish ;

Baker, Jaclyn ;

Othman, Mohamed ;

Hylek, Elaine M. .

ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) :63-69

← 1 2 3 4 →